Heba Abdelrasheed Allam

Professor of pharmaceutical chemistry

 (email)

6,7-Dimethoxy-2-methyl-4-substituted quinazolines: Design, synthesis, EGFR inhibitory activity, in vitro cytotoxicity, and in silico studies

  • View
  • What links here
Citation:
Saleh, N. S., N. N. E. El-Sayed, O. A. Saleh, H. A. Allam, N. M. Mohamed, S. E. - S. Abbas, and M. F. Said, "6,7-Dimethoxy-2-methyl-4-substituted quinazolines: Design, synthesis, EGFR inhibitory activity, in vitro cytotoxicity, and in silico studies ", European Journal of Medicinal Chemistry, vol. 290, pp. 117502, 2025.
Export
  • RTF
  • Tagged
  • XML
  • BibTex
  • Google Scholar
PreviewAttachmentSize
paper_28.pdf5.61 MB
  • Publications
  • Bio
  • Classes
  • Calendar

Recent Publications

Design and development of potent roflumilast analogues targeting PDE-4B: selectivity and pharmacokinetic insights’
Novel chalcone 2-thiopyrimidine conjugates as dual VEGFR-2/BRAF inhibitors: design, synthesis, in vitro cytotoxicity, and molecular docking study
Quinolone as a Privileged Scaffold: A Brief Overview on Early Classical and Recent Advanced Synthetic Pathways, Innovative Neuroprotective Potential, and Structure‐Activity Relationships
Design, novel one-pot green synthesis, and biological evaluation of pyrazolopyridine-congeners selectively targeting HER2+ breast cancer’
6,7-Dimethoxy-2-methyl-4-substituted quinazolines: Design, synthesis, EGFR inhibitory activity, in vitro cytotoxicity, and in silico studies
more

Login Powered by OpenScholar